| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
75,861 |
67,087 |
$3.79M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
96,629 |
85,195 |
$3.13M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
25,465 |
11,055 |
$356K |
| 80305 |
|
28,883 |
18,276 |
$254K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
2,347 |
2,125 |
$146K |
| 99223 |
Prolong inpt eval add15 m |
3,448 |
3,220 |
$145K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
23,929 |
19,122 |
$130K |
| 99233 |
Prolong inpt eval add15 m |
5,748 |
2,886 |
$117K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
3,762 |
3,458 |
$101K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,499 |
1,426 |
$99K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,128 |
3,007 |
$88K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
3,097 |
1,572 |
$60K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,372 |
1,332 |
$53K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
954 |
857 |
$52K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
5,032 |
4,305 |
$43K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
1,347 |
1,228 |
$34K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,252 |
1,209 |
$29K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,252 |
1,167 |
$28K |
| 99222 |
Initial hospital care, per day, moderate complexity |
833 |
762 |
$28K |
| 64635 |
|
625 |
565 |
$27K |
| 95886 |
|
681 |
672 |
$26K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
31 |
26 |
$23K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
641 |
622 |
$22K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
856 |
291 |
$22K |
| 93000 |
|
2,024 |
1,934 |
$21K |
| J0574 |
Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine |
656 |
369 |
$17K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,475 |
2,133 |
$17K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
302 |
298 |
$17K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
1,506 |
982 |
$16K |
| 93295 |
|
421 |
402 |
$14K |
| 95911 |
|
145 |
143 |
$13K |
| 93016 |
|
848 |
816 |
$12K |
| 64636 |
|
549 |
476 |
$12K |
| 90834 |
Psychotherapy, 45 minutes with patient |
225 |
197 |
$11K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
481 |
439 |
$10K |
| 90791 |
Psychiatric diagnostic evaluation |
144 |
134 |
$10K |
| 99215 |
Prolong outpt/office vis |
245 |
215 |
$10K |
| 94060 |
|
1,142 |
1,112 |
$9K |
| 93296 |
|
699 |
672 |
$8K |
| 0002A |
|
215 |
208 |
$8K |
| 64493 |
|
212 |
202 |
$8K |
| 0001A |
|
232 |
222 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
144 |
130 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
584 |
506 |
$8K |
| 93018 |
|
835 |
804 |
$7K |
| 95811 |
|
106 |
100 |
$6K |
| 95816 |
|
369 |
352 |
$6K |
| 99490 |
Ccm add 20min |
987 |
932 |
$5K |
| 90837 |
Psychotherapy, 53 minutes with patient |
75 |
51 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
333 |
328 |
$5K |
| 99219 |
|
88 |
86 |
$5K |
| 90686 |
|
297 |
295 |
$5K |
| 64494 |
|
211 |
201 |
$5K |
| 93298 |
|
270 |
259 |
$4K |
| 52000 |
|
72 |
71 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
125 |
122 |
$4K |
| 93299 |
|
342 |
329 |
$4K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
52 |
52 |
$4K |
| 51798 |
|
455 |
431 |
$4K |
| 95117 |
|
480 |
147 |
$3K |
| J0575 |
Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine |
101 |
67 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
86 |
69 |
$3K |
| 94729 |
|
931 |
907 |
$3K |
| 94726 |
|
854 |
830 |
$2K |
| 99205 |
Prolong outpt/office vis |
27 |
26 |
$2K |
| 93227 |
|
115 |
113 |
$2K |
| 81003 |
|
1,477 |
1,395 |
$2K |
| 99307 |
|
378 |
367 |
$2K |
| 90688 |
|
137 |
136 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
538 |
504 |
$2K |
| 97802 |
|
24 |
24 |
$2K |
| 90961 |
|
60 |
50 |
$2K |
| 99217 |
|
51 |
49 |
$1K |
| 52310 |
|
13 |
13 |
$1K |
| 64495 |
|
55 |
54 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
264 |
252 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
118 |
62 |
$1K |
| J0573 |
Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine |
78 |
36 |
$1K |
| 62323 |
|
26 |
24 |
$990.70 |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
74 |
52 |
$979.34 |
| 99225 |
|
47 |
41 |
$956.06 |
| 52332 |
|
28 |
25 |
$897.50 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$891.87 |
| 90966 |
|
51 |
50 |
$819.63 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$731.77 |
| 27096 |
|
13 |
13 |
$723.77 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
101 |
100 |
$648.50 |
| 97803 |
|
16 |
15 |
$628.07 |
| 96130 |
|
16 |
13 |
$592.60 |
| 96131 |
|
16 |
13 |
$592.60 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
70 |
61 |
$581.93 |
| 90674 |
|
26 |
26 |
$575.06 |
| 64490 |
|
14 |
13 |
$540.56 |
| 20553 |
|
16 |
14 |
$500.42 |
| 99441 |
|
26 |
26 |
$485.58 |
| 99310 |
Prolong nursin fac eval 15m |
13 |
13 |
$445.75 |
| 90661 |
|
20 |
16 |
$444.04 |
| 93294 |
|
27 |
27 |
$400.67 |
| J0572 |
Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine |
29 |
14 |
$400.18 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
29 |
27 |
$399.57 |
| 64483 |
|
13 |
12 |
$388.76 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
12 |
$351.47 |
| 94618 |
|
31 |
30 |
$307.72 |
| S9470 |
Nutritional counseling, dietitian visit |
14 |
12 |
$242.24 |
| 64491 |
|
12 |
12 |
$238.11 |
| 99442 |
|
16 |
15 |
$205.99 |
| 95819 |
|
18 |
17 |
$198.09 |
| 93272 |
|
12 |
12 |
$189.27 |
| 99421 |
|
15 |
15 |
$171.28 |
| 96160 |
|
53 |
51 |
$168.42 |
| 93297 |
|
17 |
16 |
$156.21 |
| 99224 |
|
16 |
12 |
$153.90 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
16 |
15 |
$151.40 |
| 99221 |
|
64 |
58 |
$150.44 |
| 94010 |
|
13 |
13 |
$74.12 |
| 94727 |
|
12 |
12 |
$44.79 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,232 |
1,064 |
$39.74 |
| 91300 |
|
446 |
398 |
$4.28 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
112,352 |
97,372 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
65,993 |
55,227 |
$0.00 |
| 4004F |
|
39,501 |
30,111 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
66,780 |
58,586 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
2,764 |
2,500 |
$0.00 |
| 2022F |
|
1,460 |
1,338 |
$0.00 |
| 3078F |
|
1,185 |
1,014 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
1,930 |
1,812 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
321 |
302 |
$0.00 |
| 4040F |
|
563 |
511 |
$0.00 |
| 3023F |
|
1,156 |
1,068 |
$0.00 |
| 3046F |
|
146 |
134 |
$0.00 |
| 3077F |
|
81 |
68 |
$0.00 |
| 1090F |
|
83 |
81 |
$0.00 |
| G8400 |
Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given |
12 |
12 |
$0.00 |
| 3045F |
|
33 |
29 |
$0.00 |
| 3017F |
|
29,109 |
25,836 |
$0.00 |
| 1036F |
|
52,004 |
46,422 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
10,399 |
6,928 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
6,065 |
4,103 |
$0.00 |
| 1123F |
|
735 |
675 |
$0.00 |
| 3074F |
|
998 |
861 |
$0.00 |
| G8926 |
Spirometry test not performed or documented, reason not given |
1,052 |
976 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
11,167 |
9,398 |
$0.00 |
| 3079F |
|
125 |
102 |
$0.00 |
| 1101F |
|
155 |
142 |
$0.00 |
| 3075F |
|
117 |
97 |
$0.00 |
| 3014F |
|
179 |
174 |
$0.00 |
| 3044F |
|
14 |
12 |
$0.00 |
| G8599 |
Aspirin or another antiplatelet therapy not used, reason not given |
16 |
12 |
$0.00 |